Mondae review
Mondae answers the question most of this category refuses to: who is actually compounding your medication. Its configurator names six pharmacies — Boudreaux, Rush, Hallandale, Greenwich, Align and VialsRx — and lets you choose one before checkout, which is a level of supply-chain openness worth taking seriously. The money is simple in the way that matters: $115 a month for compounded semaglutide, $145 for compounded tirzepatide, no membership fee stacked on top, and the rate held fixed as you titrate, so the number you start on is the number you keep. That flat promise is worth more than the sticker, because dose-priced plans routinely double between a starting and a maintenance dose. Both figures were checked properly rather than lifted from a marketing card: the treatment pages are a live configurator that ships a '$NNN' placeholder in the raw HTML, so the page was rendered in a browser, the resolved price read from its own element, and then cross-checked against the homepage card and the structured data the page publishes — three sources agreeing on one number. What is missing is ordinary rather than alarming: no clinician is named behind the contracted Bask Telehealth network, no labs are bundled, nothing on the site speaks to postpartum recovery, breastfeeding or PCOS, and Mondae itself warns that formulations differ across its six pharmacies and 'may contain additional additives.'
- Independently scored
- Verified
Every medical claim in this piece is footnoted to the record it came from — the trial or the FDA label — so you can read the source rather than take the masthead's word for it. No one on this desk is your clinician.
Mondae at a glance
- Semaglutide
- $115/mo (flat at every dose)
- Tirzepatide
- $145/mo (flat at every dose)
- Coverage
- All 50 states
- Brand-name
- Compounded only
How we scored Mondae
Each score comes out of Mondae's published pricing, disclosures and oversight, and the six combine into the 62/100 Editors' Rating on the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
Cost is unpredictable, premium, or hides behind a plan commitment.
Oversight and lab support fall short of the top of this roster — the review below says exactly where.
The core price is disclosed, but some conditions or add-ons aren't upfront.
Little here is shaped around a mother's week or her life stage.
Support is thin once the prescription ships.
Leaving costs you — notice windows, minimum terms or fees you don't get back.
How we verified this review
- Last verified
- August 2026
- Confidence
- high
- Primary source
- mondae.com
$115 and $145, flat at every dose, read from the page's own rendered price element because the raw HTML ships a placeholder where the number should be. A three-month plan exists, but its per-month rate is published nowhere reachable, so only the monthly figure can be confirmed.
What to expect when you sign up
We walked Mondae's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1Both monthly prices appear on the homepage and on each treatment page before intake
- 2Choose a starting dose, a plan length, and which of six named pharmacies compounds it
- 3Answer a health-history questionnaire; a licensed provider prescribes only if appropriate
- 4Medication ships from the pharmacy you picked, with tracking
What we noticed
- The configurator asks which compounding pharmacy should fill the prescription, naming six, before checkout
- The static page ships a literal '$NNN' placeholder — the real figure only appears once its scripts run
- The flat-as-your-dose-rises promise sits on the same screen as the price, not buried in an FAQ
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $115 | All doses, billed monthlyNo membership fee on top, and fixed as you titrate — Mondae's own words are that 'your dose may increase, but your price is fixed.' Confirmed three ways on 2026-08-09: the treatment card, the price its configurator renders, and the Offer price in the page's own structured data. |
| Compounded tirzepatide | $145 | All doses, billed monthlySame structure, same flat-by-dose commitment. A three-month plan exists in the configurator, but no per-month rate for it is published anywhere reachable, so it is described rather than priced here. |
Swipe the table to see plan details →
GLP-1 telehealth is usually HSA- and FSA-eligible, so check your own plan. Everything above comes from Mondae's public disclosures at last review and change often; confirm the current number on Mondae's own site.
What we like
- Names six compounding pharmacies and lets the patient choose which one fills the prescription
- $115/mo compounded semaglutide and $145/mo compounded tirzepatide, with no membership fee on top
- The rate is fixed as the dose rises, so titrating does not raise the bill
- Both prices reproduce three ways — treatment card, rendered configurator, and the page's own structured data
- All 50 states, with price and pharmacy list both visible before intake
- A prorated refund is stated policy if Mondae cannot fill a plan because of shortage or FDA action
The caveats
- The three-month plan's per-month rate is not published anywhere reachable, so only the monthly price can be confirmed
- Formulations differ across its six pharmacies and 'may contain additional additives'
- No individual clinician or medical director is named; telehealth runs through contracted Bask Telehealth LLC
- Refunds are 'not guaranteed' and medication cannot be returned once dispensed or shipped
- Cash-pay only — no in-network coverage and no federal or state program enrollment
- No labs included in the plan
- Compounded only, with no FDA-approved brand option and no oral formulation
- Nothing on the site addresses postpartum recovery, breastfeeding or PCOS
Mondae for mothers: our verdict
Mondae answers the question most of this category refuses to: who is actually compounding your medication. Its configurator names six pharmacies — Boudreaux, Rush, Hallandale, Greenwich, Align and VialsRx — and lets you choose one before checkout, which is a level of supply-chain openness worth taking seriously. The money is simple in the way that matters: $115 a month for compounded semaglutide, $145 for compounded tirzepatide, no membership fee stacked on top, and the rate held fixed as you titrate, so the number you start on is the number you keep. That flat promise is worth more than the sticker, because dose-priced plans routinely double between a starting and a maintenance dose. Both figures were checked properly rather than lifted from a marketing card: the treatment pages are a live configurator that ships a '$NNN' placeholder in the raw HTML, so the page was rendered in a browser, the resolved price read from its own element, and then cross-checked against the homepage card and the structured data the page publishes — three sources agreeing on one number. What is missing is ordinary rather than alarming: no clinician is named behind the contracted Bask Telehealth network, no labs are bundled, nothing on the site speaks to postpartum recovery, breastfeeding or PCOS, and Mondae itself warns that formulations differ across its six pharmacies and 'may contain additional additives.' It runs about $115/month, flat across every dose — toward the affordable end of what we track.
We weigh Mondae the way mothers actually have to: not just the real monthly cost, but the real monthly cost once the dose climbs and whether a real clinician stands behind it — the things a generic roundup never gets to.
What Mondae actually costs
- Compounded semaglutide — All doses, billed monthly: $115/mo
- Compounded tirzepatide — All doses, billed monthly: $145/mo
That sits below the roughly $179 median ongoing price across the providers we track for mothers — a real cost advantage.
The medications Mondae prescribes
Mondae prescribes semaglutide and tirzepatide — the pair with the strongest evidence behind them, and having both under one account matters when insulin resistance, familiar from PCOS and gestational diabetes, makes tirzepatide the better fit. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
Where Mondae fits — and where it doesn't — for mothers
Worth it if…
- the real monthly cost is a real barrier and you want a low, predictable number.
- you may need to move between semaglutide and tirzepatide as your body and hormones change.
- uninterrupted nationwide access matters — a move for family shouldn't interrupt care.
Give it a miss if…
- you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
- you'd rather a prescriber talk through timing around the real monthly cost once the dose climbs — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety, and oversight
Our confidence in Mondae's public facts is high — pricing, pharmacies, and clinical network were verifiable at last review. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our Editors' Rating methodology.
A standing caveat for mothers: GLP-1 medications aren't established as safe during pregnancy or breastfeeding, and every label advises against use. Nothing here changes that — plan the timing with your own clinician.
The bottom line
Mondae is a genuine value play — weigh it on the real monthly cost once the dose climbs and whether a real clinician stands behind it against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: A mother who wants to know — and choose — which pharmacy compounds her medication, on a flat monthly price that will not climb as her dose does.
Alternatives to Mondae
Providers we have a referral relationship with, ordered by their Editors' Rating — highest first. A fee never moves a rating, but it does decide who appears here, so this is not the whole roster: the full ranking lists every provider we cover.
- Visit CoreAge RxCoreAge RxOur #1 pick
The one program on this masthead whose number still makes sense at the top of the dose. A flat, all-in monthly price on both molecules, no teaser rate to expire, and a cancel button you can actually find — the closest thing to a family-budget guarantee we've reviewed.
- Visit Gala Health
A flat $179 for either molecule and a genuinely gentle microdosing tier — a reasonable, all-doses-included option, if you can live with a yearly plan and a pharmacy the marketing never names.
- Visit Sesame
A high-trust telehealth marketplace that took a clear side: FDA-approved brand GLP-1 only, no compounded shortcut. You pay a brand cash price and book a real video visit — but you get on-label pens and one of the cleaner reputations on this masthead.
Keep comparing Mondae
Head-to-head & alternatives
Mondae, answered
- Which pharmacy will actually compound my prescription?
- Whichever of six you choose, which is close to unique on this page. Mondae names Boudreaux, Rush, Hallandale, Greenwich, Align and VialsRx in its configurator and lets you select one before checkout. Most providers here will not name a compounder at all, so naming six and handing over the choice is the strongest disclosure signal in this listing. Read the caveat alongside it, though: Mondae states that each pharmacy ships to different states and that formulations 'may contain additional additives,' so the vial is not identical across the six — a fair question to put to the one you pick.
- Does the monthly price rise as I titrate?
- No, and Mondae puts that promise on the same screen as the price rather than in an FAQ: 'while many programs increase pricing as doses increase, your rate stays the same as long as your membership remains active.' It matters more than the sticker, because dose-priced plans commonly double between a starting dose and a maintenance dose. At $115 for compounded semaglutide and $145 for compounded tirzepatide, with no separate membership fee, the flat rate also starts low.
- How was the price verified?
- Not from the marketing card alone. Mondae's treatment pages are a live configurator, and the raw page that arrives ships a placeholder — literally '$NNN' — with the real number filled in by script. So the page was rendered in a browser and the resolved figure read out of its own price element: $115 for semaglutide at the 0.2 mg start and $145 for tirzepatide at 1.5 mg, on the one-month plan. Those match the homepage cards and the structured data the page publishes for search engines. The three-month plan is real but publishes no per-month rate anywhere a reader can reach, so no number for it appears here.
- What are the refund rules?
- Strict after dispensing, and fair in one specific way. Mondae states refunds are not guaranteed, that medication cannot be returned once dispensed or shipped, and that orders can be canceled only before dispensing. The good clause: if Mondae itself cannot fill your plan because of a supply shortage or FDA action, you get a prorated refund on the unshipped portion, calculated on the listed monthly price. Plenty of providers in this category simply keep the money in that situation.
- Who are the clinicians, and can I use insurance?
- A contracted network, and no. Mondae's Terms state telehealth is provided by a provider through Bask Telehealth LLC, drawing on physicians licensed in your state; no individual clinician or medical director is named. Its providers do not accept commercial insurance, are not in-network with any plan, and are not enrolled with Medicare or Medicaid, so there is no copay route — the $115 or $145 is what you pay.
Pricing, states and verification reflect Mondae's public disclosures at last review; the Editors' Rating is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.